while being able to culture the B-cells with standard procedures. This allows for the isolation of therapeutic antibodies from rare B-cell clones, and accelerated functional screening and ...

Traditional antibody discovery procedures are often limited by the ... anticancer activity in combination with anti-PD1 antibody therapy; and Sym023, a unique anti-TIM3 antibody with a novel ...

Immune checkpoint blockade antibodies, such as ipilimumab, are considered another therapeutic strategy against cancer due to their different mode of the antitumor mechanism and they have recently ...

Tailored to each client’s specific requirements, the Bio-Rad Pioneer Antibody Discovery Platform uses proprietary TrailBlazer™ technology to provide prototypes of therapeutic antibodies ... driving ...

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening ...

Ablexis, LLC, developer of the AlivaMab Mouse and AlivaMab Discovery Services, LLC, offer customized and streamlined solutions for companies and organizations looking to obtain efficacious and ...

Vaccination is a prominent source of novel antibodies with potential therapeutic applicability ... Analysis to learn more about how researchers used optofluidics-powered screening to find new ...

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.